Tazarotene
- Generic Name
- Tazarotene
- Brand Names
- Arazlo, Duobrii, Fabior, Tazorac
- Drug Type
- Small Molecule
- Chemical Formula
- C21H21NO2S
- CAS Number
- 118292-40-3
- Unique Ingredient Identifier
- 81BDR9Y8PS
Overview
Tazarotene, commonly marketed as Tazorac®, Avage®, and Zorac®, is member of the acetylenic class of retinoids. It is a prodrug that is found in topical formulations used in the treatment of various conditons, such as psoriasis, acne, and sun damaged skin (photodamage).
Background
Tazarotene, commonly marketed as Tazorac®, Avage®, and Zorac®, is member of the acetylenic class of retinoids. It is a prodrug that is found in topical formulations used in the treatment of various conditons, such as psoriasis, acne, and sun damaged skin (photodamage).
Indication
Used to treat psoriasis, acne and sun damaged skin (photodamage).
Associated Conditions
- Psoriasis Vulgaris (Plaque Psoriasis)
- Benign facial lentigines
- Facial fine wrinkling
- Facial hyperpigmentation
- Facial hypopigmentation
- Mild Acne vulgaris
- Moderate Acne vulgaris
Clinical Trials
FDA Approved Products
Arazlo
Manufacturer:Bausch Health US, LLC
Route:TOPICAL
Strength:0.45 mg in 1 g
Approved: 2023/09/26
NDC:0187-2098
FABIOR
Manufacturer:Mayne Pharma
Route:TOPICAL
Strength:1 mg in 1 g
Approved: 2023/02/28
NDC:51862-295
TAZAROTENE
Manufacturer:Padagis Israel Pharmaceuticals Ltd
Route:TOPICAL
Strength:1 mg in 1 g
Approved: 2023/05/17
NDC:45802-442
Tazarotene Cream
Manufacturer:E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Route:TOPICAL
Strength:1 mg in 1 g
Approved: 2018/09/28
NDC:0168-0455
TAZAROTENE
Manufacturer:Padagis Israel Pharmaceuticals Ltd
Route:TOPICAL
Strength:0.5 mg in 1 g
Approved: 2023/05/17
NDC:45802-436
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath